Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis

Myasthenia gravis (MG) is a rare debilitating autoimmune neuromuscular disorder. Many studies have focused on the mechanism and treatment strategies of MG. However, the exact pathogenesis of MG and effective treatment strategies remain unclear. Recent studies have indicated that microRNAs (miRNAs or...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yuze, Lu, Xiaoyan, Wang, Jianjian, Zhang, Huixue, Liu, Zhaojun, Xu, Si, Wang, Tianfeng, Ning, Shangwei, Xiao, Bo, Wang, Lihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358695/
https://www.ncbi.nlm.nih.gov/pubmed/28075449
http://dx.doi.org/10.3892/ijmm.2017.2853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358695/
https://www.ncbi.nlm.nih.gov/pubmed/28075449
http://dx.doi.org/10.3892/ijmm.2017.2853

Ejemplares similares